{
  "meta": {
    "title": "26_Rh_Negative_Pregnancy",
    "url": "https://brainandscalpel.vercel.app/26-rh-negative-pregnancy-467e2413.html",
    "scrapedAt": "2025-11-30T06:58:19.479Z"
  },
  "questions": [
    {
      "id": 78307,
      "choices": [
        {
          "id": 246014,
          "text": "Pre-term babies"
        },
        {
          "id": 246015,
          "text": "Rh incompatibility"
        },
        {
          "id": 246016,
          "text": "Both a and b"
        },
        {
          "id": 246017,
          "text": "None of the above."
        }
      ],
      "text": "Immediate cord ligation is done in:",
      "unique_key": "Q1319280",
      "question_audio": null,
      "question_video": null,
      "map_id": 34144653,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Rh-negative. Immediate cord ligation is recommended in Rh-negative mothers to minimize the risk of feto-maternal hemorrhage and subsequent sensitization. When the cord is clamped immediately after delivery, it reduces the chances of fetal blood mixing with maternal blood, thus lowering the likelihood of maternal Rh sensitization. This is critical to prevent hemolytic disease of the fetus and newborn (HDFN) in future pregnancies. Preterm: • Delayed cord clamping (DCC) is typically preferred in preterm infants unless contraindicated. DCC allows for improved blood volume, better oxygenation, and reduced risk of intraventricular hemorrhage (IVH). Immediate cord clamping is not routinely performed in preterm deliveries. Diabetic Pregnancy: • Immediate cord ligation is not specifically required in diabetic pregnancies. Management focuses more on neonatal glucose monitoring and addressing macrosomia or other complications. Delayed or immediate cord clamping depends on the clinical situation. Indications for Early Cord Clamping 1. Prevention of Maternal Rh Sensitization • In Rh-negative mothers, early clamping minimizes the risk of feto-maternal hemorrhage and subsequent sensitization, reducing the risk of hemolytic disease of the fetus and newborn (HDFN) in future pregnancies. 2. Neonatal Resuscitation • In cases where the newborn requires immediate resuscitation (e.g., severe asphyxia or respiratory distress), early cord clamping facilitates quick transfer to the neonatal resuscitation unit. 3. Neonatal Conditions • Polycythemia risk: Early clamping is indicated in cases where the newborn is at risk of polycythemia or hyperbilirubinemia. • Congenital anomalies: For conditions like twin reversed arterial perfusion (TRAP) sequence or congenital heart defects, early clamping may be beneficial.",
      "correct_choice_id": 246015,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/68800561697273289/68800561697273289.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/68800561697273289/68800561697273289.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78308,
      "choices": [
        {
          "id": 246018,
          "text": "50 micro gram"
        },
        {
          "id": 246019,
          "text": "200 micro gram"
        },
        {
          "id": 246020,
          "text": "300 micro gram"
        },
        {
          "id": 246021,
          "text": "100 micro gram"
        },
        {
          "id": 246022,
          "text": "All of the above doses are incorrect"
        }
      ],
      "text": "The dose of anti D gamma globulin given after term delivery for a Rh negative mother and Rh positive baby is:",
      "unique_key": "Q6496088",
      "question_audio": null,
      "question_video": null,
      "map_id": 34536022,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) 300 mcg. After a term delivery of an Rh-negative mother and an Rh-positive baby, a standard dose of 300 mcg of anti-D immunoglobulin (Rho(D) immune globulin) is administered. This dose effectively neutralizes up to 30 mL of fetal whole blood or 15 mL of fetal red blood cells that may have entered the maternal circulation during delivery. It prevents Rh sensitization, which could lead to hemolytic disease of the fetus and newborn (HDFN) in subsequent pregnancies. 50 mcg • This dose is used for first-trimester events, such as early miscarriage, ectopic pregnancy, or abortion, where the fetal blood volume is minimal. It is insufficient to cover the larger volume of fetal blood that might enter the maternal circulation during term delivery. Standard Prophylaxis at 28 Weeks: • A standard 300 mcg dose is recommended at 28 weeks of gestation for all Rh-negative mothers, regardless of invasive procedures or bleeding episodes. Kleihauer-Betke Test: • If there is a significant fetomaternal hemorrhage (FMH), such as in trauma or delivery, the Kleihauer-Betke test or flow cytometry can estimate the volume of fetal red blood cells in maternal circulation. Additional anti-D doses are calculated based on the findings.",
      "correct_choice_id": 246020,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28280281697273307/28280281697273307.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28280281697273307/28280281697273307.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78309,
      "choices": [
        {
          "id": 246023,
          "text": "Assess middle cerebral artery blood flow from 18 weeks"
        },
        {
          "id": 246024,
          "text": "Assess the amniotic fluid bilirubin levels at 18 weeks"
        },
        {
          "id": 246025,
          "text": "Determine the fetal Rhesus status by analyzing cell-free fetal DNA present in the maternal blood at 8 weeks"
        },
        {
          "id": 246026,
          "text": "Repeat the antibody titer in 4 weeks"
        }
      ],
      "text": "Rh negative G2P1 has an antibody titer of 4 IU/ml(IAT 1:4) at 8 weeks. Her husband is homozygous Rhesus positive. What is the next step in the management?",
      "unique_key": "Q6118805",
      "question_audio": null,
      "question_video": null,
      "map_id": 34901916,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Repeat titer in 4 weeks. In an Rh-negative woman with an indirect Coombs test (ICT) titer of 1:4, the first step is to repeat the antibody titer after 4 weeks to monitor the trend. A titer of 1:4 is considered low and unlikely to cause significant fetal hemolysis at this stage. Regular monitoring ensures early detection of rising antibody levels, which would prompt further evaluation and management. Reasons Why the Other Options Are Incorrect: A) Assess MCA Blood Flow • Middle cerebral artery (MCA) Doppler is used to detect fetal anemia by assessing peak systolic velocity (PSV). • It is indicated if the antibody titer reaches a critical threshold (e.g., ?1:16) or there are signs of fetal anemia. Since the titer is currently low, MCA Doppler is not warranted at this stage. B) Assess Amniotic Fluid Bilirubin Level at 18 Weeks • Measurement of amniotic fluid bilirubin is done through amniocentesis and is guided by the Liley chart to assess fetal anemia. However, this invasive procedure is only performed if there is evidence of severe sensitization or a history of hydrops fetalis. At this low titer, it is unnecessary and not the next step. It is now replaced by MCA Doppler PSV as it is reliable and non invasive C) Determine Fetal Rh Status by Cell-Free Fetal DNA Test • Cell-free fetal DNA (cffDNA) can determine fetal Rh status noninvasively. However, this is typically done earlier in pregnancy when the Rh status of the fetus is unknown.",
      "correct_choice_id": 246026,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48160511697273319/48160511697273319.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48160511697273319/48160511697273319.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78310,
      "choices": [
        {
          "id": 246027,
          "text": "Ectopic pregnancy"
        },
        {
          "id": 246028,
          "text": "Evacuation of a partial hydatidform mole"
        },
        {
          "id": 246029,
          "text": "Evacuation of retained products of conception"
        },
        {
          "id": 246030,
          "text": "Threatened abortion"
        }
      ],
      "text": "Which one the following does not require treatment with anti-D during the first trimester of pregnancy?",
      "unique_key": "Q2235797",
      "question_audio": null,
      "question_video": null,
      "map_id": 34748821,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Threatened abortion. Anti-D immunoglobulin is not routinely required for a threatened abortion in the first trimester unless there is significant vaginal bleeding or a confirmed fetal loss. In most cases of threatened abortion where the pregnancy continues and there is minimal risk of feto-maternal hemorrhage (FMH), anti-D prophylaxis is not necessary. However, it may be given in cases of significant bleeding or if miscarriage occurs. Reasons Why the Other Options Require Anti-D: A) Ectopic Pregnancy • Anti-D is required in Rh-negative women after an ectopic pregnancy because of the risk of feto-maternal hemorrhage, even though the pregnancy is outside the uterus. B) Evacuation of Partial Mole • Anti-D is indicated after the evacuation of a partial mole in Rh-negative women because the molar tissue may contain Rh-positive cells, which can lead to sensitization. C) Evacuation of RPOC (Retained Products of Conception) • Anti-D is required after the evacuation of RPOC in Rh-negative women to prevent sensitization due to the presence of fetal cells that might enter the maternal circulation. Anti-D immunoglobulin is not required in certain scenarios where there is no risk of feto-maternal hemorrhage (FMH) or the fetus is confirmed to be Rh-negative. Below are the key situations: 1. Rh-Negative Father • If the biological father of the fetus is confirmed to be Rh-negative, the fetus will also be Rh-negative, eliminating the risk of Rh sensitization. 2. Confirmed Fetal Rh-Negative Status • If the fetus is confirmed to be Rh-negative through tests like cell-free fetal DNA or amniocentesis, anti-D is not necessary. 3. Threatened Abortion Without Significant Bleeding • In cases of threatened abortion with minimal or no vaginal bleeding and no evidence of miscarriage or FMH, anti-D is typically not required. 4. First-Trimester Events Without Significant Bleeding • Routine anti-D prophylaxis is not required for minor first-trimester events without significant risk of FMH, such as: • Uncomplicated miscarriage. • Minor spotting. 5. Pre-Existing Sensitization • If the mother is already sensitized to Rh-positive blood (as confirmed by a positive indirect Coombs test or high anti-D antibody titers), administering anti-D will not provide any benefit.",
      "correct_choice_id": 246030,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/72000361697273330/72000361697273330.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/72000361697273330/72000361697273330.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78311,
      "choices": [
        {
          "id": 246031,
          "text": "12 weeks"
        },
        {
          "id": 246032,
          "text": "28 weeks"
        },
        {
          "id": 246033,
          "text": "36 weeks"
        },
        {
          "id": 246034,
          "text": "After delivery"
        }
      ],
      "text": "Best time to give Anti-D to a pregnant patient:",
      "unique_key": "Q8281799",
      "question_audio": null,
      "question_video": null,
      "map_id": 34698238,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Anti-D injection should be given to all Rh-negative pregnant females with indirect coombs test negative at 28 weeks. Dose= 300mcg Injection given intramuscularly. This will protect her present on going pregnancy. The 28-week mark is the ideal time for anti-D prophylaxis because: 1. It aligns with the increased risk of feto-maternal hemorrhage in late pregnancy. 2. It provides sustained protection until delivery. 3. It significantly reduces the risk of Rh sensitization and subsequent HDFN. Studies show that administering anti-D at 28 weeks significantly reduces the risk of Rh sensitization to less than 0.2%. • Without prophylaxis, the risk of sensitization is about 1-2% during pregnancy. Half-Life of Anti-D • The half-life of anti-D immunoglobulin is about 3 weeks. • Administering anti-D at 28 weeks provides sustained protection throughout the critical period of late pregnancy when FMH is more likely to occur.",
      "correct_choice_id": 246032,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/49420721697273342/49420721697273342.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/49420721697273342/49420721697273342.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78312,
      "choices": [
        {
          "id": 246035,
          "text": "After a spontaneous first-trimester abortion"
        },
        {
          "id": 246036,
          "text": "After treatment for ectopic pregnancy"
        },
        {
          "id": 246037,
          "text": "Within 3 days of delivering an Rh- fetus"
        },
        {
          "id": 246038,
          "text": "At the time of external cephalic version"
        }
      ],
      "text": "All of the following are scenarios in which it would have been appropriate to administer RhoGam to a Rh negative patient except",
      "unique_key": "Q8379065",
      "question_audio": null,
      "question_video": null,
      "map_id": 34460235,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Within 3 days of delivering an Rh? fetus To prevent maternal RH sensitization, pregnant women who are Rh? should receive RhoGam or Rh immune globulin (antibody to the D antigen) in the following situations: After a spontaneous or induced abortion, after an ectopic pregnancy, at the time of an amniocentesis/CVS/PUBS, at 28 weeks gestational age, within 3 days of a delivery of an Rh+ fetus, at the time of external cephalic version, with second- or third-trimester antenatal bleeding, and in the setting of abdominal trauma Explanation: No Anti-D Needed After Delivery of an Rh-Negative Fetus Anti-D immunoglobulin is not required after the delivery of an Rh-negative fetus because there are no Rh-positive fetal red blood cells to sensitize the Rh-negative mother. Sensitization occurs only if the Rh-negative mother is exposed to Rh-positive red blood cells from the fetus, which can lead to the formation of antibodies against Rh-positive cells and cause complications in future pregnancies. In some cases of first-trimester spontaneous abortion, anti-D immunoglobulin may not be necessary, depending on the circumstances. This is because the risk of feto-maternal hemorrhage (FMH) during very early pregnancy events is minimal, especially before 12 weeks of gestation. C is a better answer than A",
      "correct_choice_id": 246037,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/76068971697273355/76068971697273355.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/76068971697273355/76068971697273355.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78313,
      "choices": [
        {
          "id": 246039,
          "text": "Schedule an amniocentesis for amniotic fluid bilirubin at 16 weeks."
        },
        {
          "id": 246040,
          "text": "Repeat the titer in 4 weeks."
        },
        {
          "id": 246041,
          "text": "Repeat the titer at 28 weeks."
        },
        {
          "id": 246042,
          "text": "Schedule Percutaneous Umbilical Blood Sampling (PUBS) to determine fetal hematocrit at 20 weeks."
        }
      ],
      "text": "A 38-year-old G1P1 comes to see you for her ?rst prenatal visit at 10 weeks gestaonal age. She had a previous term vaginal delivery without any complications You also draw her prenatal labs. Two weeks later, the results of the patient’s prenatal labs come back. Her blood type is A–, with an anti-D antibody titer of 1:4. Which of the following is the most appropriate next step in the management of this patient?",
      "unique_key": "Q7242773",
      "question_audio": null,
      "question_video": null,
      "map_id": 34102664,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) For an ICT titer 1.5 MoM is noted before 35 weeks then do Confirmatory Testing: • Cordocentesis (Fetal Blood Sampling): • Performed under ultrasound guidance to: • Confirm fetal hemoglobin levels. • Assess fetal hematocrit. • Determine the severity of anemia. • No immediate fetal interventions are needed. • Continue routine prenatal care with standard ultrasound evaluations. • Escalate care if the titer rises to ?1:16, with MCA Doppler and further investigations for fetal anemia. While beyond 34 weeks with MCA PSV more than 1.5 consider delivery",
      "correct_choice_id": 246040,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7524371697273368/7524371697273368.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7524371697273368/7524371697273368.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78314,
      "choices": [
        {
          "id": 246043,
          "text": "Cordocenetsis"
        },
        {
          "id": 246044,
          "text": "MCA Doppler"
        },
        {
          "id": 246045,
          "text": "Induction of labour"
        },
        {
          "id": 246046,
          "text": "Immediate CS"
        }
      ],
      "text": "A 27-year-old G2P1 at 29 weeks gestaonal age, who is being followed for Rh isoimmunizaon presents for her OB visit. The fundal height is noted to be 33 cm. An ultrasound reveals fetal ascites and a pericardial effusion. Which of the following is the next step in the management of this patient",
      "unique_key": "Q8057120",
      "question_audio": null,
      "question_video": null,
      "map_id": 34621862,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Hydrops fetalis caused by Rh sensitization is a severe form of fetal anemia resulting from maternal antibodies attacking fetal red blood cells. The management before 34 weeks focuses on correcting fetal anemia, stabilizing the fetus, and prolonging pregnancy if possible. Management Steps 1. Confirm the Diagnosis • Ultrasound Findings: • Features of hydrops include: • Skin edema (>5 mm thickness). • Pleural effusion, pericardial effusion, or ascites. • Polyhydramnios or placentomegaly. • Cordocentesis (Fetal Blood Sampling): • Confirm fetal anemia by assessing: • Fetal hemoglobin. • Fetal hematocrit. 2. Intrauterine Transfusion (IUT) • Procedure: • Performed via the umbilical vein under ultrasound guidance. • Use O-negative, cross-matched, irradiated, leukocyte-depleted blood. Frequency: • Repeat every 1–2 weeks as needed until delivery or resolution of anemia. 3. Maternal Monitoring • Regular monitoring of antibody titers (indirect Coombs test) to track the level of Rh antibodies. • Evaluate maternal health for complications such as mirror syndrome (maternal edema and hypertension due to severe fetal hydrops). 4. Corticosteroids for Fetal Lung Maturity • Administer antenatal corticosteroids (e.g., betamethasone) between 24–34 weeks to accelerate fetal lung maturation in preparation for possible preterm delivery. 5. Regular Follow-Up • MCA Doppler Monitoring: • Repeat MCA Doppler studies every 1–2 weeks after transfusion to assess for recurrent anemia. • Ultrasound Surveillance: • Monitor for resolution of hydrops or progression of fetal distress. Plan delivery at 34 weeks",
      "correct_choice_id": 246043,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/66989601697273380/66989601697273380.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/66989601697273380/66989601697273380.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78315,
      "choices": [
        {
          "id": 246047,
          "text": "12 weeks"
        },
        {
          "id": 246048,
          "text": "20 weeks"
        },
        {
          "id": 246049,
          "text": "28 weeks"
        },
        {
          "id": 246050,
          "text": "At the time of delivery"
        }
      ],
      "text": "When should the first dose of anti-D immunoglobulin (RhoGAM) be given in an Rh-negative, unsensitized pregnant woman?",
      "unique_key": "Q5347736",
      "question_audio": null,
      "question_video": null,
      "map_id": 34038993,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) 28 weeks In an Rh-negative, unsensitized pregnant woman, the standard practice is to administer the first dose of anti-D immunoglobulin (RhoGAM) at 28 weeks of gestation. The reason for this is to prevent the mother from developing antibodies against Rh-positive fetal blood cells, which could occur if fetal-maternal hemorrhage happens, especially during the second or third trimesters. Administering RhoGAM at 28 weeks effectively reduces the risk of sensitization and potential hemolytic disease of the newborn in subsequent pregnancies. This timing is based on guidelines from organizations such as the American College of Obstetricians and Gynecologists (ACOG).",
      "correct_choice_id": 246049,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78316,
      "choices": [
        {
          "id": 246051,
          "text": "Maternal blood group typing"
        },
        {
          "id": 246052,
          "text": "Middle cerebral artery (MCA) Doppler"
        },
        {
          "id": 246053,
          "text": "Amniotic fluid bilirubin levels"
        },
        {
          "id": 246054,
          "text": "Fetal echocardiography"
        }
      ],
      "text": "What is the best test to detect fetal anemia in an Rh-sensitized pregnancy?",
      "unique_key": "Q7640934",
      "question_audio": null,
      "question_video": null,
      "map_id": 34161501,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Middle cerebral artery (MCA) Doppler In an Rh-sensitized pregnancy, the Middle Cerebral Artery (MCA) Doppler is the best test to detect fetal anemia. This test measures the peak systolic velocity (PSV) in the MCA, which increases in cases of fetal anemia due to the compensatory increase in blood flow to the brain. When the fetus is anemic, the blood becomes less viscous, and the heart pumps faster to compensate for the reduced oxygen-carrying capacity. This leads to a higher PSV in the MCA. The test is non-invasive, relatively simple to perform, and highly effective in detecting fetal anemia early in the pregnancy, allowing for timely intervention",
      "correct_choice_id": 246052,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78317,
      "choices": [
        {
          "id": 246055,
          "text": "Indirect coombs test"
        },
        {
          "id": 246056,
          "text": "Direct coombs test"
        },
        {
          "id": 246057,
          "text": "Kleihauer-Betke test"
        },
        {
          "id": 246058,
          "text": "Non-stress test"
        }
      ],
      "text": "In a previously sensitized Rh-negative mother, which test is used to monitor the severity od disease",
      "unique_key": "Q3550249",
      "question_audio": null,
      "question_video": null,
      "map_id": 34480663,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Indirect coombs test In a previously sensitized Rh-negative mother, the Indirect Coombs test is used to monitor the severity of Rh sensitization. This test detects the presence of anti-Rh antibodies in the mother's blood. When a mother has been sensitized to Rh-positive blood cells, her immune system produces antibodies against Rh-positive cells. The Indirect Coombs test measures the levels of these antibodies, which can indicate the severity of hemolytic disease of the newborn (HDN). Elevated antibody titers suggest a higher risk of fetal anemia and other complications, allowing for closer monitoring and timely intervention.",
      "correct_choice_id": 246055,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78318,
      "choices": [
        {
          "id": 246059,
          "text": "Every 2 weeks throughout pregnancy"
        },
        {
          "id": 246060,
          "text": "Every 4 weeks and throughout"
        },
        {
          "id": 246061,
          "text": "At 28 weeks"
        },
        {
          "id": 246062,
          "text": "Only if the woman develops complications"
        }
      ],
      "text": "In an Rh-negative pregnant woman, how often should the indirect coombs test (ICT) be performed if the initial test at the first visit is negative?",
      "unique_key": "Q5176592",
      "question_audio": null,
      "question_video": null,
      "map_id": 34890948,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) At 28 weeks In an Rh-negative pregnant woman, if the initial Indirect Coombs test (ICT) at the first visit is negative (meaning the mother is unsensitized), the test is typically repeated at 28 weeks of gestation. This is because, around this time, there is an increased risk of fetal-maternal hemorrhage, particularly if there is trauma or other complications such as a placental abruption or invasive procedures (e.g., amniocentesis). The 28-week test helps detect the development of anti-Rh antibodies during the pregnancy and allows for timely management, such as administering anti-D immunoglobulin (RhoGAM) to prevent sensitization.",
      "correct_choice_id": 246061,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78319,
      "choices": [
        {
          "id": 246063,
          "text": "High-dose corticosteroids"
        },
        {
          "id": 246064,
          "text": "Intrauterine blood transfusion"
        },
        {
          "id": 246065,
          "text": "Induction of labour"
        },
        {
          "id": 246066,
          "text": "Emergency CS"
        }
      ],
      "text": "What is the most effective treatment for severe fetal anemia due to Rh isoimmunization before 34 weeks?",
      "unique_key": "Q9510517",
      "question_audio": null,
      "question_video": null,
      "map_id": 34932446,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Intrauterine blood transfusion For severe fetal anemia due to Rh isoimmunization before 34 weeks of gestation, the most effective treatment is intrauterine blood transfusion (IUT). This procedure involves transfusing Rh-negative blood directly into the fetal circulation, typically through the umbilical vein, to increase the oxygen-carrying capacity of the blood and correct the anemia. IUT is the standard approach for managing fetal anemia in cases of Rh incompatibility, particularly when the fetus is at risk of hydrops fetalis or severe complications from anemia. This intervention can be repeated if necessary and is essential in saving the fetus and allowing for continued pregnancy management.",
      "correct_choice_id": 246064,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78320,
      "choices": [
        {
          "id": 246067,
          "text": "ICT positive and titer is less than 1:16"
        },
        {
          "id": 246068,
          "text": "ICT positive and titer is more than 1:16"
        },
        {
          "id": 246069,
          "text": "ICT is negative"
        },
        {
          "id": 246070,
          "text": "Fetus is Rh negative"
        }
      ],
      "text": "Which condition needs anti D",
      "unique_key": "Q1994104",
      "question_audio": null,
      "question_video": null,
      "map_id": 34383973,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) ICT is negative In an Rh-negative pregnant woman, anti-D immunoglobulin (RhoGAM) is typically given when the Indirect Coombs Test (ICT) is negative (meaning the woman is unsensitized to Rh-positive blood cells). The purpose of administering anti-D is to prevent the development of anti-Rh antibodies in the mother, which could lead to Rh sensitization and hemolytic disease of the newborn (HDN) in future pregnancies. Anti-D is usually given at 28 weeks of gestation and after delivery if the baby is Rh-positive, to prevent the formation of these antibodies if any fetal-maternal hemorrhage occurs.",
      "correct_choice_id": 246069,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78321,
      "choices": [
        {
          "id": 246071,
          "text": "50 micrograms"
        },
        {
          "id": 246072,
          "text": "100 micrograms"
        },
        {
          "id": 246073,
          "text": "300 micrograms"
        },
        {
          "id": 246074,
          "text": "500 micrograms"
        }
      ],
      "text": "If an Rh-negative mother delivers an Rh-positive baby and has a negative ICT, how much anti-D immunoglobulin should be given postpartum?",
      "unique_key": "Q8273111",
      "question_audio": null,
      "question_video": null,
      "map_id": 34953021,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) 300 micrograms If an Rh-negative mother delivers an Rh-positive baby and has a negative Indirect Coombs test (ICT) (indicating she is not sensitized to Rh-positive blood cells), 300 micrograms of anti-D immunoglobulin (RhoGAM) should be administered postpartum. This is the standard dose used to prevent Rh sensitization after delivery, in case of any fetal-maternal hemorrhage that may have occurred during labor or delivery. The 300 microgram dose is typically sufficient to neutralize any Rh-positive fetal cells in the mother’s circulation and prevent the formation of anti-Rh antibodies, which could affect future pregnancies.",
      "correct_choice_id": 246073,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78322,
      "choices": [
        {
          "id": 246075,
          "text": "Detect fetal cells in maternal circulation and determine the dose of anti-D immunoglobulin"
        },
        {
          "id": 246076,
          "text": "Confirm the baby’s Rh status"
        },
        {
          "id": 246077,
          "text": "Diagnose maternal anemia"
        },
        {
          "id": 246078,
          "text": "Assess maternal antibody titers"
        }
      ],
      "text": "The Kleihauer-Betke test is performed postpartum in an Rh-negative mother to:",
      "unique_key": "Q3025543",
      "question_audio": null,
      "question_video": null,
      "map_id": 34605135,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Detect fetal cells in maternal circulation and determine the dose of anti-D immunoglobulin The Kleihauer-Betke test is performed postpartum in an Rh-negative mother to detect the presence of fetal cells in the maternal circulation. This test is used to estimate the extent of fetal-maternal hemorrhage (i.e., how much Rh-positive fetal blood has entered the Rh-negative mother’s bloodstream). The test is particularly important because it helps determine the correct dose of anti-D immunoglobulin (RhoGAM) required to prevent Rh sensitization. If a significant amount of fetal blood is detected, a higher dose of anti-D may be needed to ensure the mother does not develop anti-Rh antibodies, which could affect future pregnancies.",
      "correct_choice_id": 246075,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78323,
      "choices": [
        {
          "id": 246079,
          "text": "Amniocentesis"
        },
        {
          "id": 246080,
          "text": "External cephalic version"
        },
        {
          "id": 246081,
          "text": "MTP at 18 weeks"
        },
        {
          "id": 246082,
          "text": "Spontaneous abortion at 7 weeks"
        }
      ],
      "text": "All the following conditions need anti D except",
      "unique_key": "Q5880077",
      "question_audio": null,
      "question_video": null,
      "map_id": 34976575,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Spontaneous abortion at 7 weeks Anti-D immunoglobulin is generally not required after a spontaneous abortion at 7 weeks if the amount of fetal-maternal hemorrhage is minimal. In early pregnancy (especially before 12 weeks), the risk of significant fetal-maternal hemorrhage is low, and anti-D is not typically administered. However, in cases of later miscarriages or more invasive procedures, it is necessary to give anti-D to an Rh-negative mother to prevent Rh sensitization. For a 7-week spontaneous abortion, standard guidelines suggest monitoring and clinical judgment; if there is a suspected larger hemorrhage or if the situation is complicated, anti-D might still be considered.",
      "correct_choice_id": 246082,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78324,
      "choices": [
        {
          "id": 246083,
          "text": ">1.0 MoM"
        },
        {
          "id": 246084,
          "text": ">1.3 MoM"
        },
        {
          "id": 246085,
          "text": ">1.5 MoM"
        },
        {
          "id": 246086,
          "text": ">2.0 MoM"
        }
      ],
      "text": "In severe Rh isoimmunization, at what MCA peak systolic velocity (PSV) value should intrauterine transfusion (IUT) be considered?",
      "unique_key": "Q7007264",
      "question_audio": null,
      "question_video": null,
      "map_id": 34790283,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) >1.5 MoM In severe Rh isoimmunization, the Middle Cerebral Artery (MCA) peak systolic velocity (PSV) is an important marker used to assess fetal anemia. The MCA PSV is measured via Doppler ultrasound and is expressed in terms of multiples of the median (MoM). A value of >1.5 MoM indicates severe fetal anemia and is a threshold for considering intrauterine blood transfusion (IUT). The increased velocity reflects reduced blood viscosity due to anemia, and the fetus may require a transfusion to prevent severe complications like heart failure or hydrops.",
      "correct_choice_id": 246085,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78325,
      "choices": [
        {
          "id": 246087,
          "text": "Repeat ICT after 2 weeks"
        },
        {
          "id": 246088,
          "text": "Give anti-D prophylaxis immediately"
        },
        {
          "id": 246089,
          "text": "Perform intrauterine transfusion (IUT)"
        },
        {
          "id": 246090,
          "text": "Plan elective delivery at 34 weeks"
        }
      ],
      "text": "A 28-year-old primigravida, Rh-negative, presents at 30 weeks. Husband is Rh-positive. Her ICT titer is 1:32. Middle cerebral artery (MCA) Doppler shows peak systolic velocity (PSV) > 1.5 MoM. What is the next best step?",
      "unique_key": "Q4716705",
      "question_audio": null,
      "question_video": null,
      "map_id": 34758768,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Perform intrauterine transfusion (IUT) Explanation: • ICT >1:16 = critical titer ? significant risk of hemolysis. • MCA PSV >1.5 MoM = fetal anemia. • At <34 weeks with fetal anemia ? IUT is indicated. • Delivery is considered if ?34–35 weeks with severe disease. • Giving anti-D at this stage is useless ? mother is already sensitized",
      "correct_choice_id": 246089,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78326,
      "choices": [
        {
          "id": 246091,
          "text": "1"
        },
        {
          "id": 246092,
          "text": "2"
        },
        {
          "id": 246093,
          "text": "3"
        },
        {
          "id": 246094,
          "text": "4"
        }
      ],
      "text": "A 25-year-old Rh-negative woman delivers an Rh-positive baby vaginally at term. She had not received antenatal prophylaxis. Following delivery, a Kleihauer–Betke (KB) test is performed and shows 2 fetal cells in maternal circulation. Estimated maternal blood volume = 5000 mL. If 1 vial of anti-D (300 µg) protects against 30 mL of fetal whole blood, what is the minimum number of vials to be administered?",
      "unique_key": "Q1871664",
      "question_audio": null,
      "question_video": null,
      "map_id": 34840495,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D)1. Calculate the Volume of Fetomaternal Hemorrhage (FMH):The prompt states that the Kleihauer-Betke test showed 2fetal cells in the maternal circulation.FMH (mL) = fetal cells × maternal blood volumeFMH (mL) = 2% × 5000 mL = 0.02 × 5000 mL = 100 mL of fetal blood.2. Determine the Number of Vials Needed:One vial of anti-D (300 µg) is sufficient to protect against 30 mL of fetal whole blood.Number of vials = (Total volume of fetal blood) / (Volume covered by one vial)Number of vials = 100 mL / 30 mL = 3.33 vials.Since you cannot administer a fraction of a vial, you must always round up it to the next whole number to ensure complete coverage. Therefore, the minimum number of vials to be administered is 4.",
      "correct_choice_id": 246094,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    }
  ]
}